Literature DB >> 16525207

Obstructive chronic pancreatitis and/or intraductal papillary mucinous neoplasms (IPMNs): a 21-year long case report.

Mohammed Abu-Hilal1, Roberto Salvia, Andrea Casaril, Neil William Pearce, Claudio Bassi, Paola Capelli, Nicola Nicoli.   

Abstract

CONTEXT: Intraductal papillary mucinous neoplasms of the pancreas (IPMNs), usually present with a picture of chronic pancreatitis and must be considered within the differential diagnosis of this condition. CASE REPORT: We report a long history of a 58-year-old male who presented with recurrent attacks of pancreatitis. He was treated for chronic pancreatitis until the age of 78 when the diagnosis of IPMN was made, but radical treatment was not possible and he was managed palliatively. The patient died of sepsis and multi-organ failure 21 years following his first presentation.
CONCLUSION: This case highlights possible pitfalls in the diagnosis and treatment of IPMNs, suggests a very long natural history, proposes possible palliative treatment in selected cases and reflects about IPMNs biological position in the chronic pancreatitis-ductal adenocarcinoma chain.

Entities:  

Mesh:

Year:  2006        PMID: 16525207

Source DB:  PubMed          Journal:  JOP        ISSN: 1590-8577


  3 in total

1.  Intraductal papillary mucinous neoplasm presenting with recurrent pancreatitis: a report of a painful 3-decade-long history.

Authors:  Samuel Raimundo Fernandes; Luís Araújo Correia; Teresa Antunes; Helena Cortez-Pinto
Journal:  BMJ Case Rep       Date:  2016-03-21

2.  Association of Chronic Pancreatitis and Malignant Main Duct IPMN: A Rare but Difficult Clinical Problem.

Authors:  Zoltán Berger; Hernán De La Fuente; Manuel Meneses; Fernanda Matamala; Makarena Sepúlveda; Claudia Rojas
Journal:  Case Rep Gastrointest Med       Date:  2017-02-22

3.  Metachronous occurrence of main-duct intraductal papillary mucinous neoplasm (IPMN) and adenocarcinoma in a chronic pancreatitis patient: A case report.

Authors:  Keum Nahn Jee
Journal:  Medicine (Baltimore)       Date:  2022-02-11       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.